{
    "2019-01-08": [
        [
            {
                "time": "",
                "original_text": "[快讯]华大基因发布质押公告 涉及股份14723万股",
                "features": {
                    "keywords": [
                        "华大基因",
                        "质押",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：控股股东质押3180万股，用途为融资",
                "features": {
                    "keywords": [
                        "华大基因",
                        "控股股东",
                        "质押",
                        "融资"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因提前完成1.5亿元增持计划，汪建增持逾1亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "增持",
                        "汪建"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因1.5亿元增持提前完成 当家人汪建增持超1亿",
                "features": {
                    "keywords": [
                        "华大基因",
                        "增持",
                        "汪建"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因董事长汪建等高管完成1.5亿元增持",
                "features": {
                    "keywords": [
                        "华大基因",
                        "董事长",
                        "汪建",
                        "高管",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "董事长汪建等增持计划完成 华大基因高管已累计增持1.8亿",
                "features": {
                    "keywords": [
                        "华大基因",
                        "董事长",
                        "汪建",
                        "增持",
                        "高管"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}